DIAGNOSTICS ACCELERATOR: DIGITAL BIOMARKERS PROGRAM
ALZHEIMER’S DRUG DISCOVERY FOUNDATION (ADDF)
Destination: Proposed approaches will be evaluated based on the existing evidence around the biological link of the symptom domain to disease and how measuring the proposed symptom domain will improve current screening or monitoring methods in patients.
Budget: Up to $500,000 (higher funding if well justified).
Fill out the form below to receive more information:
Collaborate with the IISPV and help us improve people's health through research!